Showing results (231-240 of 371) with videos related to
Sort By:
Pageof 38
Cardiovascular Research|November 30, 2022
Phenomapping in heart failure with preserved ejection fraction: insights, limitations, and future directionsAnthony E Peters, Jasper Tromp, Sanjiv J Shah, et al.The American Journal of Medicine|March 21, 2013
Angiotensin-converting enzyme inhibitors and outcomes in heart failure and preserved ejection fractionMarjan Mujib, Kanan Patel, Gregg C Fonarow, et al.JACC. Heart Failure|August 11, 2023
Frailty Status Modifies the Efficacy of ICD Therapy for Primary Prevention Among Patients With HFMatthew W Segar, Neil Keshvani, Sumitabh Singh, et al.Circulation|November 9, 2020
Association of Baseline and Longitudinal Changes in Body Composition Measures With Risk of Heart Failure and Myocardial Infarction in Type 2 Diabetes: Findings From the Look AHEAD TrialKershaw V Patel, Judy L Bahnson, Sarah A Gaussoin, et al.Circulation. Cardiovascular Imaging|October 3, 2014
Longitudinal assessment of concurrent changes in left ventricular ejection fraction and left ventricular myocardial tissue characteristics after administration of cardiotoxic chemotherapies using T1-weighted and T2-weighted cardiovascular magnetic resonanceJennifer H Jordan, Ralph B D'Agostino, Craig A Hamilton, et al.JACC. Heart Failure|November 30, 2019
Impact of Age on Comorbidities and Outcomes in Heart Failure With Reduced Ejection FractionJessica A Regan, Dalane W Kitzman, Eric S Leifer, et al.Circulation. Heart Failure|October 22, 2011
Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION studyG Michael Felker, Mona Fiuzat, Linda K Shaw, et al.Hypertension (Dallas, Tex. : 1979)|January 17, 2007
Genome-wide linkage mapping for valve calcification susceptibility loci in hypertensive sibships: the Hypertension Genetic Epidemiology Network StudyJonathan N Bella, Weihong Tang, Aldi Kraja, et al.Circulation|May 16, 2023
Racial Differences in Quality of Life in Patients With Heart Failure Treated With Sodium-Glucose Cotransporter 2 Inhibitors: A Patient-Level Meta-Analysis of the CHIEF-HF, DEFINE-HF, and PRESERVED-HF TrialsKashvi Gupta, John A Spertus, Mary Birmingham, et al.American Heart Journal|March 31, 2015
Authorship in a multicenter clinical trial: The Heart Failure-A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) Authorship and Publication (HAP) scoring system resultsDavid J Whellan, William E Kraus, Dalane W Kitzman, et al.Pageof 38